- Home
- LSF vs MDAI Comparison
LSF vs MDAI Comparison
Compare LSF & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSF
- MDAI
- Stock Information
- Founded
- LSF 2015
- MDAI 2013
- Country
- LSF United States
- MDAI United States
- Employees
- LSF N/A
- MDAI N/A
- Industry
- LSF Packaged Foods
- MDAI Medical/Dental Instruments
- Sector
- LSF Consumer Staples
- MDAI Health Care
- Exchange
- LSF Nasdaq
- MDAI Nasdaq
- Market Cap
- LSF 61.6M
- MDAI 51.9M
- IPO Year
- LSF 2020
- MDAI N/A
- Fundamental
- Price
- LSF $5.64
- MDAI $2.06
- Analyst Decision
- LSF Strong Buy
- MDAI Strong Buy
- Analyst Count
- LSF 2
- MDAI 1
- Target Price
- LSF $12.00
- MDAI $3.50
- AVG Volume (30 Days)
- LSF 33.5K
- MDAI 275.7K
- Earning Date
- LSF 11-05-2025
- MDAI 11-05-2025
- Dividend Yield
- LSF N/A
- MDAI N/A
- EPS Growth
- LSF N/A
- MDAI N/A
- EPS
- LSF N/A
- MDAI N/A
- Revenue
- LSF $47,027,546.00
- MDAI $27,549,000.00
- Revenue This Year
- LSF $21.88
- MDAI N/A
- Revenue Next Year
- LSF $20.86
- MDAI $60.05
- P/E Ratio
- LSF N/A
- MDAI N/A
- Revenue Growth
- LSF 22.79
- MDAI 22.27
- 52 Week Low
- LSF $3.60
- MDAI $0.82
- 52 Week High
- LSF $10.90
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- LSF 40.11
- MDAI 51.82
- Support Level
- LSF $5.68
- MDAI $1.78
- Resistance Level
- LSF $5.99
- MDAI $2.02
- Average True Range (ATR)
- LSF 0.23
- MDAI 0.11
- MACD
- LSF 0.03
- MDAI 0.03
- Stochastic Oscillator
- LSF 7.52
- MDAI 81.94
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.